-
201
Clinical significance of PCT, CRP, IL-6, NLR, and TyG Index in early diagnosis and severity assessment of acute pancreatitis: A retrospective analysis
Published 2025-01-01Subjects: “…Acute Pancreatitis (AP)…”
Get full text
Article -
202
Treatment of inoperable pancreatic adenocarcinoma with focused ultrasound and microbubbles in patients receiving chemotherapy
Published 2025-06-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
203
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice
Published 2025-01-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
204
NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
Published 2025-01-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
205
Novel therapy modalities combining photodynamic therapy and liposomal cisplatin for pancreatic cancer treatments
Published 2025-03-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
206
Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
Published 2024-09-01Subjects: Get full text
Article -
207
Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
Published 2025-01-01Subjects: Get full text
Article -
208
AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
209
Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells
Published 2023-09-01Subjects: “…pancreatic cancer…”
Get full text
Article -
210
A stumbling block in pancreatic cancer treatment: drug resistance signaling networks
Published 2025-01-01Subjects: “…pancreatic cancer…”
Get full text
Article -
211
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
Published 2024-12-01Subjects: “…pancreatic cancer…”
Get full text
Article -
212
The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021
Published 2025-01-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
213
RBM47 promotes cell proliferation and immune evasion by upregulating PDIA6: a novel mechanism of pancreatic cancer progression
Published 2024-12-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
214
Primary pancreatic hepatoid carcinoma: A case report
Published 2025-02-01Subjects: “…Pancreatic hepatoid carcinoma…”
Get full text
Article -
215
LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype
Published 2024-12-01Subjects: Get full text
Article -
216
The therapeutic potential of vitamins A, C, and D in pancreatic cancer
Published 2025-01-01Subjects: Get full text
Article -
217
Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
Published 2025-02-01Subjects: Get full text
Article -
218
Benign biliary stricture caused by transduodenal lumen-apposing metal stent placement for pancreatic acute necrotic collection
Published 2025-01-01Subjects: Get full text
Article -
219
Skin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study
Published 2025-02-01Subjects: Get full text
Article -
220
Sarcopenia as a Prognostic Factor of Hepatotoxicity and Lower Survival Rate in Chemotherapy of Pancreatic Cancer
Published 2020-07-01Subjects: “…pancreatic cancer…”
Get full text
Article